[CML] gleevec stromal tumors

[ICANDOALLTTC]

Double dose of new cancer drug not required Reported by Susan Aldridge, PhD, medical journalist A new study underlines the efficiency of imatinib in a rare form of stomach cancer. Imatinib mesylate (Gleevec) is a very effective new anti-cancer drug that first proved its worth in the treatment of chronic myeloid leukemia. Now it's been shown to work on gastrointestinal stromal tumors (GIST), a type of soft tissue tumor previously treatable only by surgery (after which it usually recurs). Further study into the effect of Gleevec and GIST involving 746 patients in 57 institutions showed that doubling the dose is not necessary. The response rate was about 50 per cent whether the patient received 400 milligrams or 800 milligrams a day of the drug. Response here means that the tumor either shrank or stayed the same. Ongoing research is checking whether the double dose might be helpful to patients whose tumor continues to grow with a standard dose of Gleevec. New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: cml@yahoogroups.com Subscribe:  [EMAIL PROTECTED] Unsubscribe:  [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED]  CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Sponsor ADVERTISEMENT Yahoo! Groups Links To visit your group on the web, go to: http://groups.yahoo.com/group/CML/   To unsubscribe from this group, send an email to: [EMAIL PROTECTED]   Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.